An amyloid beta-protein fragment, A beta[12-28], equipotently impairs post-training memory processing when injected...

Area of Science:

• Neuroscience
• Molecular Biology
• Cognitive Science

Background:

• Amyloid beta-protein (A beta) fragments have been previously shown to impair memory.
• Specific A beta fragments (1-28, 12-28, 12-20) were identified as amnestic when administered intracerebroventricularly.
• The precise brain regions targeted by these fragments remain incompletely understood.

Purpose of the Study:

• To investigate the dose-dependent amnestic effects of A beta peptide 12-28.
• To determine the specific brain structures sensitive to the memory-impairing effects of A beta peptide 12-28.
• To explore the potential mechanism of A beta-induced cognitive dysregulation.

Main Methods:

• Stereotactic microinjections of A beta peptide 12-28 into various brain regions of mice.
• Testing retention performance following footshock active avoidance training.
• Dose-response analysis of amnestic effects in different brain loci.

Main Results:

• A beta peptide 12-28 impaired memory retention when injected into limbic structures (amygdala, caudate, hippocampus, mammillary bodies, septum).
• The amnestic effect was observed with similar efficacy across these limbic regions.
• Injection of A beta peptide 12-28 into the medial thalamus did not produce any amnestic effects.

Conclusions:

• A beta peptide 12-28 selectively impairs memory processing within limbic brain structures.
• The medial thalamus appears to be a non-sensitive region to the amnestic effects of this A beta fragment.
• A beta may cause cognitive deficits through the dysregulation of K(+)-channel function in neural and non-neural cells.